| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.68 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |